Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Engineered antibodies to combat viral threats

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Nature 588, 398-399 (2020)

doi: https://doi.org/10.1038/d41586-020-03196-2

References

  1. Bournazos, S., Corti, D., Virgin, H. W. & Ravetch, J. V. Nature 588, 485–490 (2020).

    Article  Google Scholar 

  2. Nimmerjahn, F. & Ravetch, J. V. Nature Rev. Immunol. 8, 34–47 (2008).

    PubMed  Article  Google Scholar 

  3. Urquhart, L. Nature Rev. Drug Discov. 19, 228 (2020).

    PubMed  Article  Google Scholar 

  4. Liu, R., Oldham, R. J., Teal, E., Beers, S. A. & Cragg, M. S. Antibodies 9, 64 (2020).

    Article  Google Scholar 

  5. Shields, R. L. et al. J. Biol. Chem. 276, 6591–6604 (2001).

    PubMed  Article  Google Scholar 

  6. Beers, S. A., Glennie, M. J. & White, A. L. Blood 127, 1097–1101 (2016).

    PubMed  Article  Google Scholar 

  7. Chan, K. R., Ong, E. Z., Mok, D. Z. & Ooi, E. E. Expert Rev. Anti-Infect. Ther. 13, 1351–1360 (2015).

    PubMed  Article  Google Scholar 

  8. Minard-Colin, V. et al. Blood 112, 1205–1213 (2008).

    PubMed  Article  Google Scholar 

  9. Goncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H. & Lai, C.-J. Proc. Natl Acad. Sci. USA 104, 9422–9427 (2007).

    PubMed  Article  Google Scholar 

  10. Kerntke, C., Nimmerjahn, F. & Biburger, M. Front. Immunol. 11, 118 (2020).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

M.S.C. acts as a consultant for a number of biotech companies, being retained as a consultant for BioInvent, and has received research funding from BioInvent, GSK, UCB, iTeos and Roche. None of these associations relate to antiviral therapy.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links